Skip to main content

CME for Primary Care: Top Topics in 2026

Posted by Carlton Smith

CME for Primary Care: Top Topics in 2026

Primary care practice has recently seen a widening scope and greater patient complexity. As a primary care provider, you may treat many types of conditions in outpatient settings, such as cardiovascular prevention, women's health and more, and changing guidelines underscore the importance of consistent CME learning to reinforce clinical decision-making. See the top trends you can expect to encounter in family medicine and internal medicine this year.

Obesity Medicine and Metabolic Health

Obesity and metabolic health now represent a greater component of primary care, mainly due to advances in pharmacotherapy and understanding of obesity as a chronic condition. GLP-1 receptor agonists and dual GIP/GLP-1 agonists, including semaglutide and tirzepatide, have demonstrated clinically significant weight reduction alongside improvements in hemoglobin A1c, blood pressure and lipid parameters. This evidence supports ongoing treatment and demonstrates the importance of obesity and metabolic care as part of longitudinal disease management.

These changes prompt practical considerations within primary care. Insurance coverage varies by indication and payer, often requiring prior authorization and frequent documentation updates. Drug shortages and intermittent access may complicate treatment continuity, while adverse effects, such as gastrointestinal symptoms and gallbladder disease, may necessitate counseling and monitoring. Current guidance emphasizes combining pharmacotherapy with nutrition, physical activity and cardiometabolic risk assessment.

Mental Health Integration

With the prevalence of mental health conditions, primary care is increasingly integrating mental health services to improve access and enable comprehensive preventive care. Integrated mental health and primary care models embed behavioral health into medical settings using team-based and collaborative approaches, with professionals such as behavioral health consultants potentially accessible in primary care settings and primary care providers coordinating with nurse practitioners and mental health professionals.

Evidence for integrated mental health and primary care models shows improved outcomes for depression and anxiety when medication management, symptom tracking and psychiatric input occur within primary care workflows. Primary care clinicians frequently prescribe SSRIs and SNRIs, which requires CME learning in topics relating to managing titration, adverse effects, drug interactions and discontinuation strategies.

The U.S. Preventive Services Task Force also recommends routine depression screening in adults and adolescents and anxiety screening in adults younger than 65. These guidelines also help address the youth mental health crisis, in addition to care involving family engagement and school and community resources.

Cardiovascular Prevention

Cardiovascular prevention guidelines have evolved according to changing risk stratification and treatment thresholds. Lipid management increasingly extends beyond statins, particularly for patients who do not meet LDL-C targets or experience intolerance. Non-statin therapies such as ezetimibe, PCSK9 inhibitors and bempedoic acid have demonstrated incremental LDL-C reduction and cardiovascular risk reduction. Clinical decision-making now requires individualized sequencing based on baseline risk, cost and patient preference.

Guidelines also suggest more individualized management for blood pressure, with lower systolic targets for patients deemed high-risk. Other populations may experience negative effects from aggressive lowering and may increase the risk of hypotension. Coronary artery calcium scoring is utilized more frequently to assess risk, since it allows clinicians to measure subclinical atherosclerosis before lipid levels or other traditional risk factors become evident.

Adult Immunization Updates

Adult immunization recommendations have been recently updated to incorporate newly approved vaccines and revised age- and risk-based indications. Key recommendations include:

  • Respiratory syncytial virus (RSV): The CDC guidance supports vaccination for adults aged 60 and older using shared clinical decision-making and recommends routine vaccination beginning at age 75. Adults aged 60 to 74 with chronic lung disease, cardiovascular disease, diabetes or immunocompromising conditions have higher risk for severe RSV-associated lower respiratory tract disease.
  • Pneumococcal disease: Adults who have not previously received a pneumococcal conjugate vaccine may receive a single dose of PCV20 or PCV15 followed by PPSV23, depending on age and clinical risk factors. This update simplifies prior multi-dose schedules and adjusts protection to individual risk profiles.
  • Herpes zoster (shingles): Recombinant zoster vaccine is recommended for all adults aged 50 and older and for immunocompromised adults aged 19 and older, regardless of prior shingles history or receipt of the live zoster vaccine.
  • COVID-19: The CDC recommends the COVID-19 vaccine to maintain protection from new circulating strains. Adults are advised to receive updated doses according to age, immunocompromising conditions and time since prior vaccination or infection, following current CDC guidance. As of November 4, 2025, CDC guidelines have also been updated to reflect individual-based decision-making.

Women’s Health

Recent changes in women's health emphasize midlife care and long-term risk reduction. Following the resurgence of hormone replacement therapy, current recommendations for menopause management support individualized hormone replacement therapy for symptomatic patients without contraindications. Access to contraception has also expanded with approval of over-the-counter oral contraceptives, such as Opill, a norgestrel-based and FDA-approved daily birth control pill.

Osteoporosis screening and treatment for women are consistent with prior guidelines, though there are changes to screening methods. Recommendations now suggest bone mineral density screening for post-menopausal women under 65 with risk factors. Within the types of bone density screening, guidelines emphasize the use of DEXA scans and FRAX.

Applying CME to Daily Primary Care Practice

As guidelines change, prioritize your CME learning on your specific patient population to optimize clinical care and patient outcomes. Focused, evidence-based updates and point-of-care resources allow you to adapt to evolving standards across chronic disease management, prevention and pharmacotherapy. Get started today and explore Oakstone CME products.